Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG

SANN

Rank in Stocks #15443
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The companyโ€™s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Share Price
$17.48
Last synced: 2026-11-13
Market Cap
$250.88M
Change (1 day)
-3.61%
Change (1 year)
16.41%
Country

Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this

Trade Santhera Pharmaceuticals Holding AG (SANN)

Category

Healthcare
Operating Margin for Santhera Pharmaceuticals Holding AG (SANN)
Operating Margin as of November 2026 TTM: -8.93%
According to Santhera Pharmaceuticals Holding AG's latest financial reports, its current operating margin (TTM) is -8.93%. At the end of 2025 the company had an operating margin of -48.99%.
Operating Margin history for Santhera Pharmaceuticals Holding AG from 2006 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -8.93% -81.77%
2025 -48.99% -42.59%
2024 -85.34% -228.20%
2023 66.57% -109.57%
2022 -695.52% -119.50%
2021 3,566.65% -1,108.53%
2020 -353.65% 2,453.43%
2019 -13.85% -91.47%
2018 -162.43% -26.14%
2017 -219.91% 26.35%
2016 -174.05% -337.03%
2015 73.43% -125.31%
2014 -290.12% -47.64%
2013 -554.13% -37.07%
2012 -880.58% 5.65%
2011 -833.48% 1,871.80%
2010 -42.27% -98.51%
2009 -2,835.73% -97.01%
2008 -94,981.25% 28,052.60%
2007 -337.38% -90.80%
2006 -3,666.97% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -78.12%
US
33.87% -103.79%
US
-116.04% -87.01%
US
25.57% -102.86%
AU
31.23% -103.50%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Santhera Pharmaceuticals Holding AG's operating margin

What is Santhera Pharmaceuticals Holding AG's operating margin?

Santhera Pharmaceuticals Holding AG's operating margin is -8.93%, as of Nov 2026.

What was Santhera Pharmaceuticals Holding AG's operating margin in 2025?

In 2025, Santhera Pharmaceuticals Holding AG's operating margin was -48.99%, compared with -85.34% in 2024.

How has Santhera Pharmaceuticals Holding AG's operating margin changed since 2020?

From 2020 to 2025, Santhera Pharmaceuticals Holding AG's operating margin was highest in 2021 (3,566.65%) and lowest in 2022 (-695.52%).

How does Santhera Pharmaceuticals Holding AG's operating margin compare with similar companies?

Santhera Pharmaceuticals Holding AG's operating margin (-8.93%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.